Based on our cumulative research reviews and analyses, we report two major findings:
Major bilateral, multilateral, and private philanthropic AIDS donors and national governments do notconsistently track or publicly report their HIV investments targeted at MSM or transgender people inlow- and middle-income countries.2.
When data is available, funding levels for MSM and transgender people in low- and middle-incomecountries are not commensurate to the epidemiological burden and needs of these populations.
With very few exceptions, a majority of HIV donors do not track or publicly report investmentstargeted at MSM and transgender people. Only 25% of all national governments reported on HIVprevention spending on MSM in 2010 while none reported HIV prevention spending on transgenderpeople. Thus, overall investment targeted at HIV prevention, treatment, care, and support services forMSM and transgender people in low- and middle-income countries remains unknown.More specifically, our research revealed that only 2% of total HIV prevention spending was targeted atMSM in 42 low- and middle-income countries. This was based on national HIV spending from bothdomestic and international sources reported by these countries over a two-year period between 2008and 2009. We were unable to ascertain prevention spending on transgender people as this was notreported. Without the necessary parameters, total spending on treatment and care focused on MSMand transgender people is nearly impossible to disaggregate from coverage rates for these services.While there are also no reliable estimates of overall spending on advocacy for MSM and transgenderpeople, in general advocacy and rights-based approaches were more likely to receive support fromprivate philanthropic donors.Our analysis was made difficult by the scarcity of population-specific information available from donoragencies or in publicly reported financials. Our findings nonetheless illuminate the scarcity of resourcesthat ultimately reach MSM and transgender people in low- and middle-income countries. Building onthese findings, we discuss key implications for the global AIDS response and provide recommendationsfor a way forward. These recommendations are targeted at donors and national governments but alsointended for civil society advocates and HIV stakeholders who must all work collaboratively toward anequitable AIDS response worldwide. In order to make progress in the global effort to halt AIDS,bilateral, multilateral, and private philanthropic AIDS donors and national governments must immediatelylead efforts to increase, track, and publicly report HIV investments targeted at MSM and transgenderpeople.An appendix section included at the end of this report includes the following attachments:1.
Information about donors:
A listing of donor agencies included in our review with brief descriptions and useful links as relevant.2.
Chart on stand-out investments:
Although an overall estimate on MSM and transgender HIVinvestments remains unknown, we use this chart to feature stand-out investments that werecorded during our desk reviews and qualitative interviews.3.
National HIV Prevention Spending Data:
A table that lists national HIV prevention spendingdata for 39 low- and middle-income countries (overall spending versus spending on MSM) in